U.S. Food and Staples Retail Stock News

AGCO recently announced that its Valtra brand has produced the 1,000th continuously variable transmission at its Suolahti, Finland factory, marking an important milestone in a €38 million investment program to boost local powertrain manufacturing for Valtra, Fendt, and Massey Ferguson tractors. This progress in in‑house CVT production highlights AGCO’s push to tighten control over key components, which could influence manufacturing efficiency, product differentiation, and regional supply...

The housing debate in Washington just got very real for investors. A bipartisan bill to cap institutional ownership of single family homes and encourage new construction puts fresh attention on companies that actually build and deliver housing. If private equity buyers are capped at 350 homes, demand could shift back toward owner occupiers and smaller investors, while incentives for building may support construction activity. Below are 3 stocks from our Homebuilders & Residential Construction...

Denali Therapeutics Inc. previously announced it had entered into a definitive agreement to sell its FDA Rare Pediatric Disease Priority Review Voucher for US$195,000,000 in cash, following the accelerated approval of AVLAYAH (tividenofusp alfa) for Hunter syndrome. The move converts a one-time regulatory award into substantial non-dilutive funding, giving Denali additional flexibility to progress its lysosomal storage and neurodegenerative disease programs without issuing new equity. We’ll...

With Wall Street now bracing for potential rate hikes in 2026 instead of cuts, interest rate sensitivity has jumped back to the top of the checklist for many stock pickers. Persistent 4.2% inflation, a firm labor market, and a hawkish Federal Reserve are reshaping which companies could benefit from higher yields, and which might feel the strain of rising borrowing costs and pressure on real estate and credit. This article breaks down three stocks exposed to that story, spotlighting two that...

Taysha Gene Therapies (TSHA) has drawn fresh attention after completing patient dosing in its pivotal REVEAL trial of TSHA-102 for Rett syndrome and sharing longer-term safety and functional outcome data. See our latest analysis for Taysha Gene Therapies. The Rett data release has arrived alongside a sharp shift in how the market prices Taysha Gene Therapies, with a 30 day share price return of 16.94% and a year to date share price return of 22.29%. The 1 year total shareholder return of...

Golar LNG (NasdaqGS:GLNG) has attracted fresh attention after recent share price moves, with the stock trading around $49.60. Investors are weighing its liquefied natural gas infrastructure focus in relation to its mixed short term return figures. See our latest analysis for Golar LNG. Recent share price moves around $49.60 come after a year where Golar LNG’s share price return is up 30.70% year to date, while the 3 year total shareholder return of 170.90% and 5 year total shareholder return...

Flowserve (FLS) is back in focus as investors react to its greater push into higher margin service and digital monitoring offerings tied to critical energy and water infrastructure projects. See our latest analysis for Flowserve. Recent trading reflects that shift in focus, with the share price up 17.37% over the past 30 days and 15.48% year to date, while Flowserve’s 1 year total shareholder return of 78.44% and 3 year total shareholder return of 136.79% point to strong momentum rather than...

Venture Global (NYSE:VG) has signed new and expanded LNG supply agreements with Germany's EnBW and Greece’s Atlantic-SEE. The Atlantic-SEE contract has been doubled, increasing Venture Global's contracted LNG volumes into Europe. These agreements deepen the company's role as a U.S. LNG supplier to European utilities focused on long-term energy diversification. Venture Global is a U.S. liquefied natural gas exporter, and its latest deals with EnBW and Atlantic-SEE add fresh detail to how the...

It's been a sad week for The Kroger Co. ( NYSE:KR ), who've watched their investment drop 12% to US$56.61 in the week...

Danaher Corporation ( NYSE:DHR ) stock is about to trade ex-dividend in three days. Typically, the ex-dividend date is...

Mercury Systems (MRCY) recently reported year-over-year revenue growth of 8.03% and a 118.77% increase in net profit, along with a fresh technical buy signal that has refocused attention on the stock. See our latest analysis for Mercury Systems. At a share price of $113.91, Mercury Systems has pulled back slightly in the very short term, with a 1-day share price return of 1.38% and 7-day share price return of 1.74%. The 30-day and 90-day share price returns of 15.59% and 52.92% respectively,...

In recent months, Krystal Biotech has seen its institutional shareholding score reach the maximum of 10.00, with major investors such as ETHSX and BlackRock increasing their positions and lifting overall institutional ownership by 11.17% quarter-over-quarter. This sharp rise in institutional participation places Krystal Biotech at the top of its Biotechnology & Medical Research peer group for institutional backing, highlighting stronger professional investor interest despite limited...

Global trade rules are getting tougher, and regulators are paying closer attention to how companies manage compliance, data, and supply chain risk. For investors, that creates a clear filter: focus on businesses that help corporates stay on top of complex rules and avoid costly missteps, and be wary of those that might struggle if governance and audit demands keep building. This article looks at three stocks from a Compliance and Risk Management Software Providers screener that appear well...

With fresh import tariffs returning under the Trump Administration and new trade probes targeting forced labor and industrial overcapacity, investors are being pushed to rethink how exposed their portfolios are to global supply chains. Larger U.S. manufacturers could stand to gain if domestic production becomes relatively more attractive; yet the picture is far from simple. This article breaks down how the renewed tariff push connects to U.S. Domestic Manufacturing Stocks and highlights three...

The SpaceX and Reflection AI deal, worth up to US$6.3b in computing power commitments, puts a fresh spotlight on the infrastructure behind artificial intelligence. This kind of contract shows how valuable high-end chips, data centers, and cloud-style capacity have become for any company trying to scale AI. For investors, it opens up a chance to reassess which stocks might benefit from rising demand for compute and which could be left on the sidelines. This article walks through 3 stocks from...

In June 2026, Tonies SE and Hasbro launched three classic Hasbro games, MONOPOLY, GUESS WHO?, and THE GAME OF LIFE, reimagined as screen-free, audio-first experiences for the Tonieplay platform on Toniebox 2, with a phased global rollout beginning in the U.S. over the summer. This collaboration highlights how Hasbro is extending its board game brands into new formats that blend interactive storytelling with off-screen play, reinforcing its push into higher-margin, digitally enabled...

The United States market has experienced a steady climb, rising 1.4% over the last week and 26% over the past year, with earnings projected to grow by 19% annually in the coming years. In this context, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on discounts relative to their intrinsic value amidst overall market optimism.

Over the last seven days, the United States market has risen by 1.4%, and over the past 12 months, it has increased by 26%, with earnings forecasted to grow annually by 19%. In this thriving environment, a good stock often combines robust growth potential with significant insider ownership, indicating confidence from those who know the company best.

The market has shown positive momentum, climbing 1.4% over the last week and 26% over the past year, with earnings anticipated to grow by 19% annually. While penny stocks may seem like a term from a bygone era, they still offer potential for significant returns when aligned with solid financial foundations. In this context, we explore three compelling penny stocks that demonstrate both balance sheet strength and promising growth potential.

The U.S. decision to grant a temporary license for Iranian oil exports adds a fresh twist to the energy story, with extra supply potential and questions around the Strait of Hormuz all feeding into cost expectations for heavy oil users. For companies in transportation, chemicals, and logistics, even small shifts in fuel prices can influence margins, pricing power, and investor sentiment. This article looks at 3 stocks from the Oil-Importing Industries screener that may warrant closer review...

Envista Holdings (NVST) is drawing fresh attention after a sharp quarterly rise in institutional ownership, combined with technical indicators that currently flag the stock as a potential range-bound trading candidate. See our latest analysis for Envista Holdings. The recent uptick in institutional buying comes on top of a 1 month share price return of 10.58% and a year to date share price return of 19.46%. The 1 year total shareholder return of 37.09% contrasts with weaker 3 and 5 year total...

Recent updates showed Capital Southwest delivered strong year-over-year growth in both revenue and net profit, reinforcing its already solid financial position despite relatively low operating efficiency. At the same time, institutional ownership has fallen while at least one major fund manager modestly added to holdings, highlighting differing views on the stock’s current setup. Next, we’ll examine how this combination of stronger profitability and shifting institutional ownership affects...

RealReal (REAL) has drawn fresh attention after recent trading, with the stock moving sharply over the past month and over the past three months. Investors are weighing that price action against the company’s resale luxury marketplace profile. See our latest analysis for RealReal. Recent trading has come on top of a strong run in RealReal’s share price, with a 30 day share price return of 35.33% and a 90 day share price return of 40.68%, set against a year to date share price decline of...

Edgewise Therapeutics (EWTX) drew fresh investor attention after reporting favorable Phase 2 Part D CIRRUS-HCM data for EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy, with results supporting progression to Phase 3 development. See our latest analysis for Edgewise Therapeutics. The Phase 2 CIRRUS-HCM update lands at a time when Edgewise Therapeutics has already seen strong momentum, with a 1-month share price return of 12.57% and a year-to-date share price return of...